| Title |
Blood pressure lowering efficacy of coenzyme Q10 for primary hypertension
|
|---|---|
| Published by |
John Wiley & Sons, Ltd, October 2009
|
| DOI | 10.1002/14651858.cd007435.pub2 |
| Pubmed ID | |
| Authors |
Ho, Meghan J, Bellusci, Anthony, Wright, James M |
| Abstract |
Studies have shown that coenzyme Q10 deficiency is associated with cardiovascular disease. Hypertension is a commonly measured surrogate marker for non-fatal and fatal cardiovascular endpoints such as heart attacks and strokes. Clinical trials have suggested that coenzyme Q10 supplementation can effectively lower blood pressure (BP). |
Mendeley readers
The data shown below were compiled from readership statistics for 68 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Australia | 2 | 3% |
| Canada | 1 | 1% |
| Unknown | 65 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 15 | 22% |
| Researcher | 12 | 18% |
| Student > Master | 11 | 16% |
| Student > Postgraduate | 8 | 12% |
| Student > Ph. D. Student | 6 | 9% |
| Other | 10 | 15% |
| Unknown | 6 | 9% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 36 | 53% |
| Nursing and Health Professions | 10 | 15% |
| Agricultural and Biological Sciences | 8 | 12% |
| Biochemistry, Genetics and Molecular Biology | 4 | 6% |
| Pharmacology, Toxicology and Pharmaceutical Science | 2 | 3% |
| Other | 1 | 1% |
| Unknown | 7 | 10% |